JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) — Stock Price

Rs2408.90 INR
▼ -3.87% today

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) is currently trading at Rs2408.90 INR, down 3.87% today. Over the past 52 weeks, shares have ranged between Rs1656.70 and Rs2506.00. This page tracks JB Chemicals & Pharmaceuticals Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see JBCHEPHARM company net worth.

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks JB Chemicals & Pharmaceuticals Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

JB Chemicals & Pharmaceuticals Limited Income Statement — Revenue, Profit & Earnings by Year

JB Chemicals & Pharmaceuticals Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs41.48 Billion Rs38.62 Billion Rs34.48 Billion Rs31.17 Billion Rs24.24 Billion
Cost of Revenue Rs22.51 Billion Rs13.40 Billion Rs12.03 Billion Rs11.85 Billion Rs8.43 Billion
Gross Profit Rs18.96 Billion Rs25.22 Billion Rs22.45 Billion Rs19.32 Billion Rs15.81 Billion
Research & Development — Rs448.40 Million Rs305.63 Million Rs319.33 Million Rs291.07 Million
SG&A Rs5.08 Billion Rs362.53 Million Rs6.03 Billion Rs5.47 Billion Rs4.41 Billion
Total Operating Expenses Rs9.71 Billion Rs16.67 Billion Rs14.92 Billion Rs13.44 Billion Rs11.11 Billion
Operating Income Rs9.25 Billion Rs8.55 Billion Rs7.53 Billion Rs5.87 Billion Rs4.71 Billion
EBITDA Rs11.07 Billion Rs10.69 Billion Rs9.33 Billion Rs7.05 Billion Rs5.83 Billion
EBIT Rs9.25 Billion Rs8.98 Billion Rs7.95 Billion Rs5.91 Billion Rs5.10 Billion
Interest Expense Rs55.70 Million Rs106.91 Million Rs436.51 Million Rs347.29 Million Rs39.72 Million
Income Before Tax Rs9.52 Billion Rs8.87 Billion Rs7.52 Billion Rs5.55 Billion Rs5.05 Billion
Income Tax Expense Rs2.43 Billion Rs2.28 Billion Rs1.99 Billion Rs1.45 Billion Rs1.19 Billion
Net Income Rs7.09 Billion Rs6.60 Billion Rs5.53 Billion Rs4.10 Billion Rs3.85 Billion

JB Chemicals & Pharmaceuticals Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes JB Chemicals & Pharmaceuticals Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs49.69 Billion Rs42.74 Billion Rs39.94 Billion Rs35.54 Billion Rs26.07 Billion
Total Current Assets Rs29.09 Billion Rs19.23 Billion Rs18.53 Billion Rs15.28 Billion Rs12.75 Billion
Cash & Equivalents — Rs360.00 Million Rs235.02 Million Rs269.12 Million Rs18.20 Million
Short-term Investments Rs7.39 Billion Rs3.35 Billion Rs3.71 Billion Rs2.16 Billion Rs1.06 Million
Net Receivables Rs7.81 Billion Rs9.02 Billion Rs7.04 Billion Rs5.77 Billion Rs5.98 Billion
Inventory Rs6.83 Billion Rs5.29 Billion Rs5.03 Billion Rs4.30 Billion Rs4.10 Billion
Property, Plant & Equipment — Rs6.57 Billion Rs6.35 Billion Rs5.76 Billion Rs5.67 Billion
Goodwill Rs574.60 Million Rs574.60 Million Rs574.59 Million Rs574.60 Million Rs574.59 Million
Total Liabilities Rs8.09 Billion Rs8.40 Billion Rs10.71 Billion Rs10.74 Billion Rs4.69 Billion
Total Current Liabilities Rs5.91 Billion Rs6.32 Billion Rs8.68 Billion Rs5.54 Billion Rs3.84 Billion
Long-term Debt — Rs0.00 Rs236.40 Million Rs3.83 Billion —
Net Debt Rs-1.42 Billion Rs-1.02 Billion Rs2.89 Billion Rs4.96 Billion Rs-19.85 Million
Total Stockholder Equity Rs41.59 Billion Rs34.33 Billion Rs29.23 Billion Rs24.80 Billion Rs21.34 Billion
Retained Earnings Rs33.29 Billion Rs29.31 Billion Rs25.13 Billion Rs22.76 Billion Rs18.43 Billion

JB Chemicals & Pharmaceuticals Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how JB Chemicals & Pharmaceuticals Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs7.11 Billion Rs9.02 Billion Rs8.01 Billion Rs6.26 Billion Rs1.70 Billion
Capital Expenditures Rs831.90 Million Rs975.90 Million Rs2.61 Billion Rs7.65 Billion Rs7.07 Billion
Free Cash Flow Rs6.27 Billion Rs8.05 Billion Rs5.39 Billion Rs-1.39 Billion Rs-5.37 Billion
Investing Cash Flow Rs-5.96 Billion Rs-2.96 Billion Rs-4.08 Billion Rs-9.62 Billion Rs23.20 Million
Financing Cash Flow Rs-1.20 Billion Rs-5.80 Billion Rs-3.41 Billion Rs3.57 Billion Rs-1.38 Billion
Dividends Paid Rs3.13 Billion Rs2.37 Billion Rs1.57 Billion Rs1.28 Billion Rs1.28 Billion
Stock-Based Compensation Rs710.10 Million Rs549.00 Million Rs419.67 Million Rs693.70 Million Rs626.53 Million
Depreciation Rs1.82 Billion Rs1.71 Billion Rs1.38 Billion Rs1.14 Billion Rs726.60 Million
Change in Cash Rs284.84 Million Rs268.70 Million Rs110.51 Million Rs203.90 Million Rs340.70 Million

JB Chemicals & Pharmaceuticals Limited Earnings History — EPS Actual vs. Analyst Estimates

Track JB Chemicals & Pharmaceuticals Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 30, 2026 — — —
May 11, 2026 7.60 8.40 -9.52%
Jan 16, 2026 12.45 12.50 -0.40%
Nov 10, 2025 13.08 12.90 +1.40%
Jul 30, 2025 12.75 13.60 -6.25%
May 14, 2025 9.17 8.83 +3.85%
Feb 04, 2025 10.24 10.20 +0.39%
Nov 06, 2024 10.92 11.00 -0.73%